MKKGY - MERCK Kommanditgesellschaft auf Aktien

Other OTC - Other OTC Delayed Price. Currency in USD

MERCK Kommanditgesellschaft auf Aktien

Frankfurter Strasse 250
Darmstadt 64293
49 6151 72 0

IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees53,051

Key Executives

NameTitlePayExercisedYear Born
Dr. Stefan OschmannChairman of Exec. Board & CEON/AN/A1957
Dr. Marcus KuhnertCFO & Member of Exec. BoardN/AN/A1968
Dr. Kai BeckmannCEO of Performance Materials & Member of the Exec. BoardN/AN/A1965
Dr. Udit BatraCEO of Life Science & Member of Exec. BoardN/AN/A1971
Ms. Belén Garijo López M.D.CEO of Healthcare & Member of the Exec. BoardN/AN/A1960
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It offers prescription medicines to treat cancer, multiple sclerosis, infertility, growth deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, as well as squamous cell carcinoma of the head and neck; diagnostics and prescription drugs for allergen immunotherapy; and fertility treatments. The company also provides life science products and services for use in the discovery, development, and manufacture of drug therapies, as well as in laboratories; and specialty chemicals for use in displays, computer chips, surfaces, Integrated circuits, microelectronic systems, anti-reflection coatings, and cosmetics. It has alliances with Pfizer Inc., Bristol-Myers Squibb Company, Intrexon Corporation, Avillion LLP., F-star Delta Ltd, SFJ Pharmaceuticals Group, Alibaba Health, Checkmate Pharmaceuticals, Solvias, and Leap Therapeutics, Inc.; a collaboration with Daiichi Sankyo Company, Limited; a co-development agreement with Oncolytics Biotech Inc.; a partnership with GlucoMe LTD; and collaboration agreements with Phosplatin Therapeutics LLC and Vyriad Inc. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

Corporate Governance

MERCK Kommanditgesellschaft auf Aktien’s ISS Governance QualityScore as of July 29, 2019 is 8. The pillar scores are Audit: 5; Board: 5; Shareholder Rights: 9; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.